Showing results (91-100 of 406) with videos related to
Sort By:
Pageof 41
Therapeutic Innovation & Regulatory Science|November 29, 2021
Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient SelectionCynthia Huber, Tim Friede, Julia Stingl, et al.Statistics in Medicine|April 2, 2026
Bayesian Random-Effects Meta-Analysis of Aggregate Data on Clinical EventsChristian Röver, Qiong Wu, Anja Loos, et al.Biometrical Journal. Biometrische Zeitschrift|October 19, 2016
Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseasesTim Friede, Christian Röver, Simon Wandel, et al.Journal of Biopharmaceutical Statistics|January 8, 2014
Adaptive designs for confirmatory clinical trials with subgroup selectionNigel Stallard, Thomas Hamborg, Nicholas Parsons, et al.Journal of Occupational Medicine and Toxicology (London, England)|July 25, 2014
Work-related outcomes in randomised placebo-controlled pain trials: a systematic review and meta-analysisIngmar Wolf, Tim Friede, Ernst Hallier, et al.Pharmaceutical Statistics|September 11, 2023
Interim decision making in seamless trial designs: An application in an adaptive dose-finding study in a rare kidney diseaseOlympia Papachristofi, Björn Bornkamp, Melanie Wright, et al.Plos One|September 2, 2015
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-RegressionChristian Röver, Richard Nicholas, Sebastian Straube, et al.Statistics in Medicine|June 6, 2022
A straightforward meta-analysis approach for oncology phase I dose-finding studiesChristian Röver, Moreno Ursino, Tim Friede, et al.Statistics in Medicine|November 19, 2016
A studentized permutation test for three-arm trials in the 'gold standard' designTobias Mütze, Frank Konietschke, Axel Munk, et al.Clinical Trials (London, England)|April 8, 2017
Using phase II data for the analysis of phase III studies: An application in rare diseasesSimon Wandel, Beat Neuenschwander, Christian Röver, et al.Pageof 41